Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released May 11, 2026, after the close
10-Q filed May 11, 2026, 41 days after period end · 0000320017-26-000032
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$4.49M | -$4.72M | -$5.40M | -$6.19M |
| EPS Diluted | -$0.50 |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.55 |
| -$0.65 |
| -$0.77 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
